KR102494694B1 - Medicament inhaler - Google Patents

Abstract

The present invention discloses a medicament vaporizing inhaler. The present invention is configured so that when a patient with respiratory disease inhales a particulate drug, the drug is included in the vaporized vapor, so that the drug can reach the lungs of the patient with respiratory disease sufficiently and stably without loss, so that some of the drug is prevented from staying in the inhalation container, and while preventing excessive inhalation of the drug, the efficiency of drug inhalation of patients with respiratory diseases is improved.

Description

Drug vaporization inhaler {MEDICAMENT INHALER}

The present invention relates to a vaporizing drug inhaler, and more particularly, when a patient with a respiratory disease inhales a particulate drug, the inhaled particulate drug is mixed with vaporized vapor and reaches the lungs of the patient with a respiratory disease in a stable and sufficient manner. It relates to a drug vaporization inhaler that enables

In general, as civilization develops, modern people suffer from diseases called civilizational diseases such as bronchial asthma and atopy due to various pollution and pollution.

As a solution to the above problems, aromatherapy or drugs can be used anytime, anywhere, regardless of time and place in order to increase mental and physical stability and immunity, and to obtain the effect of replacing the negative culture of our society, such as health promotion and cigarettes. A lot of research has been done on portable inhalers to obtain .

That is, in drugs developed for the treatment of patients with respiratory diseases such as asthma, in addition to administration of bronchial active compounds in the form of metered aerosols and inhalable solvents, the use of inhalation powders containing active substances is particularly important.

Especially in the case of active substances with high potency, only a small amount of active substance per single administration is required to achieve a therapeutic effect. In this case, an inhalation powder is prepared by diluting the active substance with suitable excipients.

Due to the large amount of excipients, the properties of the inhalation powder are greatly influenced by the choice of excipients. When choosing an excipient, its particle size is of particular importance. Generally, the finer the excipient, the poorer its flow properties.

However, good flow properties when packaging and dividing individual doses of the dosage form, for example when preparing capsules (inhalettes) for powder inhalation or for metering individual doses before the patient uses a multi-dose powder inhaler. is a necessary condition for highly accurate weighing.

Additionally, the particle size of the excipient is very important to the release properties of the capsule when used in an inhaler. It is also reported that the particle size of an excipient has a significant effect on the proportion of the active substance in the inhalation powder delivered by inhalation. The term inhalation rate of active substance refers to the particles of the inhaled powder that, when inhaled with the breath, migrate deep into the branches of the lungs. The particle size required for this is 1 to 10 μm, preferably less than 6 μm.

However, in conventional powder inhalers that inject fine powder into fine particles, when inhaling the fine particulate drug, the inhaled particulate drug was not sufficiently inhaled to the lungs, and a part of the drug frequently remained in the inhaler. Accordingly, in the prior art, There was a problem in that patients with respiratory diseases inhaled an excessive amount of the drug in consideration of the amount of loss.

Public Utility Model Publication No. 20-1999-0039904 (published on November 15, 1999) Registered Patent Publication No. 10-1017850 (Public date 2011.02.21.) Registered Patent Publication No. 10-1281699 (Announcement Date 2013.07.03.) Publication No. 10-2016-0105800 (published on September 7, 2016) Publication No. 10-2018-0040379 (published on April 20, 2018) International Patent Publication No. WO 2004-112702 (published on December 29, 2004) International Patent Publication No. WO 2011-020554 (published on February 24, 2011)

The problem to be solved by the present invention is to configure the drug to be included in the vaporized vapor when a patient with a respiratory disease such as asthma inhales a particulate drug, so that the drug can reach the lungs of a patient with a respiratory disease stably without loss, An object of the present invention is to provide a medicament vaporization inhaler that prevents a portion of the medicament from remaining in the inhaler and prevents excessive inhalation of the medicament.

delete

The drug vaporization inhaler, which is a means for solving the problems of the present invention, includes an inhaler body in which a battery and a control board are accommodated; a particulate vaporizer accommodated inside the upper end of the inhaler body and generating heat when power is supplied from the battery to vaporize the vaporization accelerating composition; It is detachably coupled to the upper part of the body of the inhaler, and on the upper surface is formed a capsule accommodating portion for accommodating a capsule in which a powder medicine for patients with respiratory diseases is hermetically stored. a body portion having a guide passage for vapor discharge communicating with the particulate vaporization portion so as to eject vaporized vapor derived from the capsule toward the capsule located in the capsule accommodating portion; And, by being rotatably coupled to the upper surface of the body portion to form a mixing space, having a suction contact pipe for respiratory disease patients communicating with the mixing space and a capsule incision pin for cutting the capsule accommodated in the capsule accommodating portion, a lid portion for inhaling the vaporized vapor through the inhalation contact pipe or the vaporized vapor discharged from the capsule into the vaporized vapor guided through the guide passage and inhaled into the lungs of patients with respiratory diseases; is to include

According to one aspect of the present invention, one end of the inhaler body is electrically connected to the battery and a charging terminal block having a charging terminal for charging the battery is formed, and the other end of the inhaler body is electrically connected to the battery. It is to form a power supply block having a heating terminal for supplying power to the particulate vaporization unit while being electrically connected to the control board.

According to another aspect of the present invention, the particulate vaporization unit constitutes one disposable cartridge, which has a certain length, and includes an adsorption core material bundle filled with a vaporization promoting composition in an amount of 3 to 5 suctions; a heating coil wrapped around a middle portion of the adsorption core bundle and having both ends electrically connected to the charging terminal; a non-smoke film filter having a cylindrical structure accommodating the adsorption core material bundle around which the heating coil is wound; an upper cover made of plastic coupled to an upper end of the non-flammable film filter having a cylindrical structure and having an outlet for discharging vaporization vapor for the vaporization accelerating composition toward the guide passage; and a lower cover made of plastic coupled to a lower end of the non-flammable filter forming a cylindrical structure and through which both ends of the heating coil pass through so as to be electrically connected to the charging terminal; is to include

delete

In addition, the vaporization accelerating composition may be any one of minerals, vitamins, amino acids, and physiologically active agents.

According to another aspect of the present invention, the capsule accommodating portion comprises a pair of plate-shaped first wall members supporting the left and right side surfaces of the capsule, and is installed apart from the first wall member in a different direction to form a capsule A pair of arc-shaped second wall members facing each other supporting both ends of the plate-shaped second wall member, and between the plate-shaped first wall member and the arc-shaped second wall member, when the lid is rotated, one surface of the upper side of the capsule It is to form a pin movement passage so as to be cut.

According to another aspect of the present invention, the body portion is coupled at the upper portion of the inhaler body, a rail groove for guiding rotation of the lid portion is formed on an upper edge side of the body portion, and protrusions are inserted at both ends of the rail groove. to form a groove.

According to another aspect of the present invention, a pair of capsule incision pins protrude from the inner end of the lid portion, and a locking protrusion seated in the protrusion insertion groove of the body portion on the inner edge side of the lid portion and rotating along the rail groove is to form

According to another aspect of the present invention, the outer circumferential surface of the body portion in which the protrusion insertion groove is formed and the outer circumferential surface of the lid portion in which the locking protrusion is formed are discharged positions of only vaporized vapor through the suction contact pipe, or the capsule. It is possible to form first and second display units for guiding a mixed steam discharge position so that the powdered medicine discharged from the vaporized vapor can be discharged.

According to another aspect of the present invention, the guide passage is the mixing space provided between the lid and the body when vaporized steam is ejected toward the capsule placed between the body and the lid. It can be formed in a torsion tubular shape penetrating up and down to form a vortex inside.

According to another aspect of the present invention, the guide passage forms an "L"-shaped passage that is connected from a bottom surface of the body to an inner wall surface of the capsule accommodating part, and the inner outlet of the passage is configured to form a passage in the capsule accommodating part. It is preferable to be positioned adjacent to a pin movement passage provided in a space spaced apart between the plate-shaped first wall member and the arc-shaped second wall member.

According to another aspect of the present invention, the guide passage is connected in a transverse direction from the vertical passage along with a vertical passage formed to face vertically from the bottom surface of the body, and the outlet thereof is the inner wall surface of the capsule accommodating part. By having a horizontal flow path formed to be opened to, it is formed to form a connection passage having a "b"-shaped cross section as a whole.

According to another aspect of the present invention, the horizontal flow path opened to the inner wall surface of the capsule accommodating unit is installed to maintain an inclination of 15 to 45° from the center of the body to one side, and the steam is discharged through the particulate vaporization unit. The vaporized steam ejected through the dragon's guide passage is directed toward the incision surface of the capsule whose upper side is incised due to the capsular incision pin for partial incision of the capsule surface, and at the same time to form a vortex in the mixing space it is desirable

As such, the present invention is configured so that when a respiratory disease patient inhales a particulate drug, the drug is included in the vaporized vapor, so that the drug can reach the lungs of the respiratory disease patient sufficiently without loss, so that some of the drug It is possible to expect the effect of improving the efficiency of drug inhalation of patients with respiratory diseases while preventing them from staying in the inhalation container and preventing excessive inhalation of the drug.

The effects of the present invention are not limited to the effects mentioned above, and other effects not mentioned will be clearly understood by those skilled in the art from the description of the claims.

1 is an exploded perspective view showing the structure of a drug vaporization inhaler according to an embodiment of the present invention.
Figure 2 is an exploded cross-sectional view showing the structure of a drug vaporization inhaler according to one embodiment of the present invention.
Figure 3 is a cross-sectional view showing the structure of a drug vaporization inhaler according to an embodiment of the present invention.
Figure 4 is an enlarged perspective view showing an exploded structure of a body portion and a lid portion in one embodiment of the present invention.
Figure 5 is an exploded perspective view showing the structure of the particulate vaporization unit in one embodiment of the present invention.
Figure 6 is a perspective view of a combination of a battery, a control board and a terminal block accommodated in the respirator body in one embodiment of the present invention.
Figure 7 is a top plan schematic view of Figure 4 showing one embodiment of the present invention.
Figure 8 is a bottom schematic view of Figure 4 showing one embodiment of the present invention.

Hereinafter, embodiments of the present invention will be described with reference to the accompanying drawings.

1 is an exploded perspective view showing the structure of a drug vaporization inhaler according to an embodiment of the present invention, Figure 2 is an exploded cross-sectional view showing the structure of a drug vaporization inhaler according to an embodiment of the present invention, and FIG. As an example, it is a combined cross-sectional view showing the structure of a drug vaporization inhaler, and FIG. 4 is an enlarged perspective view showing an exploded structure of a body portion and a lid portion according to an embodiment of the present invention.

5 is an exploded perspective view showing the structure of a particulate vaporizer according to an embodiment of the present invention, and FIG. 6 is a perspective view of a battery, a control board, and a terminal block accommodated in a respirator body according to an embodiment of the present invention, and FIG. is a schematic plan view of FIG. 4 showing an embodiment of the present invention, and FIG. 8 is a schematic bottom view of FIG. 4 showing an embodiment of the present invention.

1 to 8, the drug vaporization inhaler according to an embodiment of the present invention includes a respirator body 10, a particulate vaporization unit 20, a body unit 30, and a lid unit 40. to include

The respirator body 10 can accommodate the particulate vaporization unit 20, and the battery 11 and the control board 12 are accommodated therein, as well as one end of the inhaler body 10. While electrical connection with the battery 11 is made, a charging terminal block 13 having a charging terminal 13a for charging the battery 11 is formed, and the other end of the inhaler body 10 is formed with the battery 11 and A power supply block 14 having a heating terminal 14a supplying power to the particulate vaporization unit 20 while being electrically connected to the control board 12 that is electrically connected can be formed.

The particulate vaporization unit 20 vaporizes the vaporization accelerating composition while generating heat when power is supplied from the battery 11, which constitutes one disposable cartridge and is accommodated inside the top of the respirator body 10 , It includes an adsorption core material bundle 21, a heating coil 22, a non-smoke film filter 23, an upper cover 24, and a lower cover 25.

The adsorption core material bundle 21 is provided with a certain length, and it is preferable that the vaporization acceleration composition is filled with the suction amount 3 to 5 times. This is to prevent subsequent contamination.

delete

delete

On the other hand, the vaporization accelerating composition is an element harmless to the human body, and may be any one of minerals, vitamins, amino acids, and physiologically active agents.

Nutrients in general are water, protein, lipid, carbohydrate, insoluble dietary fiber, soluble dietary fiber, total dietary fiber and sugar, or minerals such as calcium, phosphorus, iron, sodium, magnesium, manganese, zinc, cobalt, selected from any one or a combination of two or more of copper, molybdenum, selenium, fluorine, iodine, ash, calcium, phosphorus, iron, sodium, and zinc; As vitamins, any one of vitamin A, retinol (RE), beta-carotene, thiamine, riboflavin, niacin, vitamin C, vitamin B6, pantothenic acid, vitamin B12, folic acid, vitamin D, vitamin E, vitamin K, vitamins, and thiamine or a combination of two or more; Isoleucine, leucine, lysine, methionine, cysteine, phenylalanine, tyrosine, threonine, tryptophan, valine, histidine, arginine, aspartic acid, glutamic acid, glycine, proline, serine selected from any one or a combination of two or more; As bioactive agents, daidzein, genistein, glycetin, cyanidin, delphinidin, malvidin, pelargonidin, phenonidin, feturidine, epicatechin, epicatechin 3-galette, epicalocatechin, epicalocatechin 3- Galet, catechin, gallocatechin, eriodicchol, hesperetin, naringenin, epignin, luteolin, isohamnetin, kaempferol, myricetin, quercetin, monomeric proanthocyanidin, dimer proanthocy Anidine, trimer proanthocyanidin, 4-6 proanthocyanidin, 7-10 proanthocyanidin, polymeric proanthocyanidin, choline, betanin, procholine, glycerophosphocholine, phospho Any one of choline, phosphatidylcholine, and sphingomyelin or a combination of two or more may be selected.

The vaporization accelerating composition also contains amino acids, Gingko Biloba, Coenzyme Q10 (Co-Q10), Phosphatidyl Serine (PS), Alpha Lipoic Acid, inorganic salts, and minerals ingredients; Any one of tea components from green tea, dungulae, Schisandra chinensis tea, wheatgrass tea, corn beard tea, plum tea, tangerine peel tea, dermal tea, chrysanthemum tea, quince, quince, kudzu, goji berry, cornus officinalis, persimmon leaf, duchung, oolong, and donggyuja tea; Any one fruit component of orange, lemon, and grapefruit; A vegetable component of any one of broccoli extract, cabbage extract, onion, garlic, ginger, lettuce extract, kale extract, bellflower extract, and tomato extract; Ginkgo biloba, bokbunja, wolfberry, Schisandra chinensis, Sasangja, Tosaja, Cornus officinalis, and any one of herbal ingredients; It may further include a group selected from one or a combination of two or more functional ingredients of any one of royal jelly, plum, raisin tree, and xylitol.

The heating coil 22 is wound around the middle portion of the adsorption core bundle 21, and both ends can be electrically connected to the heating terminal 14a, and both ends of the heating coil 22 are insulated. It is wrapped with a covering material (not shown).

The non-combustible film filter 23 has a cylindrical structure accommodating the adsorption core material bundle 21 around which the heating coil 22 is wound.

The upper cover 24 is a plastic material coupled to the upper end of the non-smoke filter 23 constituting a cylindrical structure, and has a discharge port 24a for discharging vaporization vapor for the vaporization accelerating composition toward the guide passage 33 to be described later. that can be formed.

The lower cover 25 is a plastic material coupled to the lower end of the non-smoke filter 23 constituting a cylindrical structure, and both ends of the heating coil 22 are penetrated so as to be electrically connected to the heating terminal 14a. It can.

The body part 30 is detachably coupled to the upper part of the respirator body 10, and the capsule receiving part 32 for accommodating the capsule 31 in which the powder medicine for patients with respiratory diseases is hermetically stored is recessed on the upper surface. It is formed, and a guide passage 33 for discharging steam communicating with the outlet 24a is formed as a penetrating type in the upper and lower regions. It can be formed to be located on the outside toward the capsule 31 .

In addition, a rail groove 34 for guiding the rotation of the lid 40 is formed on the edge side of the upper surface of the body portion 30, and protrusion insertion grooves 35 are formed at both ends of the rail groove 34. that can be formed.

The capsule accommodating portion 32 shows the capsule accommodating portion 32 in the form of being depressed from the upper surface of the body portion 30, and consists of a pair to support the left and right side surfaces of the capsule 31 A plate-shaped first wall member 32a and a pair of arc-shaped second wall members facing each other that are installed apart from each other in a direction different from the first wall member 32a to support both ends of the capsule 31 (32b), between the plate-shaped first wall member 32a and the arc-shaped second wall member 32b, when the lid 40 is rotated, one surface of the upper side of the capsule 31 is incised. The pin movement passage 32c is secured as much as possible.

In addition, the lid part 40 is rotatably coupled to the upper surface of the body part 30, and the mixing space facing the capsule accommodating part 32 provided on the upper surface of the body part 30 has an inner lower part ( 41) is formed.

In the center of the mixing space 41, a suction contact pipe 42 for respiratory disease patients connected upward is formed in an open structure that penetrates vertically, and on the inner bottom surface of the lid part 40, the capsule accommodating part 32 ) The capsule cutting pin 43 for partially cutting the surface of the capsule 31 accommodated in the capsule protrudes downward.

The capsule cutting pin 43 for partially incising the surface of the capsule is provided on the upper surface of the body portion 30 when the lid portion 40 is rotated, and the plate-shaped first wall surface of the capsule receiving portion 32 is provided. An upper surface of the capsule 31 placed in the capsule accommodating part 32 is incised while passing through the pin movement passage 32c provided as a space spaced apart between the member 32a and the arc-shaped second wall member 32b. By doing so, the powdered medicine can be discharged from the capsule 31.

The capsule is accommodated in a fixed state by the plate-shaped first wall member 32a and the arc-shaped second wall member 32b outside the capsule accommodating portion 32 provided on the upper surface of the body portion 30. A guide passage 33 is formed so that vaporized steam can be ejected toward (31).

The guide passage 33 is formed in a shape in which the capsule accommodating part 32 is recessed, and together with the vertical passage 33a formed from the bottom surface of the body 30 in a vertical direction, the vertical passage 33 A horizontal passage 33b connected in the transverse direction from the passage 33a and having its outlet open to the inner wall surface of the capsule accommodating part 32 can be formed to form a connection passage having an “L”-shaped cross section as a whole. There is.

At this time, the horizontal passage 33b opened to the inner wall surface of the capsule accommodating part 32 maintains an inclination of 15 to 45° from the center of the body part 30 to one side, which is the discharge port 24a. ) so that the vaporized steam ejected through the guide passage 33 for steam discharge is directed toward the incision surface of the capsule 31 whose upper side is incised due to the capsule incision pin 43 for partial incision on the capsule surface. At the same time, the mixture provided between the lid part 40 and the body part 30 while rotating and mixing the powdered medicine separated from the incision surface of the capsule 31 due to the vaporization steam ejection pressure ejected from both directions up and down. This is to enable the formation of a vortex in the space 41 .

In other words, the outlet of the guide passage 33 is a pin movement passage 32c provided in a space spaced apart between the first wall member 32a and the second wall member 32b in the capsule accommodating part 32. It is to be installed facing.

As a result, the vaporized steam ejected toward the capsule 31 can directly contact the powdered medicine discharged from the capsule 31 whose upper surface is cut due to the capsule cutting pin 43 for partial incision on the capsule surface, , Through this, it is possible to maximize the powder drug mixing effect.

A locking protrusion 44 seated in the protrusion insertion groove 35 and rotated along the rail groove 34 is formed on the inner edge side of the lid portion 40, and the protrusion insertion groove 35 is formed. First and second display portions T1 and T2 may be formed on the outer circumferential surface of the body portion 30 and the outer circumferential surface of the lid portion 40 where the locking protrusion 44 is formed, respectively.

The first and second display parts T1 and T2 are provided according to the rotation range of the cover part 40 without damaging the capsule 31 located in the capsule accommodating part 32. Only the vaporized pure vapor induced through the inlet can be selectively discharged through the suction contact pipe 42, or the powder medicine discharged from the capsule 31 is included in the vaporized vapor and discharged as a powder mixture gas It is to be able to guide you to a position where you can be.

As such, the drug vaporization inhaler according to the embodiment of the present invention, as shown in the accompanying FIGS. 1 to 8, first includes a battery 11 and a control board 12, and a charging terminal block 13 for electrical connection and a power source. In a state in which the particulate vaporizing unit 20 constituting one disposable cartridge is accommodated inside the upper end of the respirator body 10 in which the supply block 14 is accommodated, the schedule included in the particulate vaporizing unit 20 The suction amount of the vaporization accelerating composition is filled in the long adsorption core material bundle 21 3 to 5 times.

Thereafter, the heating coil 22 included in the particulate vaporization unit 20 is connected to the heating terminal 14a of the power supply block 14 formed on the control board 12 electrically connected to the battery 11 and In the electrically connected state, the capsule 31 in which the powdered drug in the form of particulates is hermetically stored is seated in the capsule accommodating portion 32 of the body portion 30.

Thereafter, while the body portion 30 is spirally coupled to the upper portion of the respirator body 10, the cover portion 40 is coupled to the upper portion of the body portion 30.

Next, by manipulating a button (not shown) formed at one end of the respirator body 10, the control board 12 in the respirator body 10 supplies power from the battery 11 to the microparticles through the heating terminal 14a. When supplied to the heating coil 22 included in the vaporizing unit 20, the heating coil 22 generates heat by vaporizing the vaporization accelerating composition filled in the adsorbent core material bundle 21 to generate steam. Steam is discharged to the guide passage 33 formed in the body part 30 through the outlet 24a of the upper lid 24 included in the particulate vaporizing part 20 .

At this time, when the respiratory disease patient wants to inhale only the vaporized vapor discharged through the guide passage 33, the respiratory disease patient has first and second airways formed on the outer circumferential surfaces of the body portion 30 and the lid portion 40. 2 Minimize the rotation of the lid part 40 while watching the display parts T1 and T2.

That is, when the locking protrusion 44 formed on the lid part 40 is seated in one end of the protrusion seating groove 35 formed on the body part 30 and then rotated along the rail groove 34, the Rotation of the lid part 40 is minimized so as not to pass through the pin movement passage 32c formed in the capsule accommodating part 32 .

Then, the capsule 31 seated in the capsule accommodating part 32 is not cut by the capsule cutting pin 43 formed in the lid part 40, and the discharge of the powdered medicine from the capsule 43 Accordingly, when a respiratory disease patient breathes while holding the inhalation contact pipe 42 formed in the lid portion 40 in the mouth, only vapor vaporized through the guide passage 33 enters the lungs of the respiratory disease patient. that can be reached

On the other hand, when a respiratory disease patient mixes the powdered medicine in the capsule 31 with the vaporized vapor discharged through the guide passage 33 and then inhales it, the respiratory disease patient mixes the vaporized vapor discharged through the guide passage 33 and then inhales it. While watching the first and second display portions T1 and T2 formed on the outer circumferential surface of the portion 40, the amount of rotation of the cover portion 40 is increased.

That is, after the locking protrusion 44 formed on the lid part 40 is seated in one end of the protrusion seating groove 35 formed on the body part 30, the capsule is rotatably guided along the rail groove 34. The amount of rotation of the lid part 40 is increased so that the pin passes through the moving path 32c formed in the accommodating part 32 and is seated in the protrusion seating groove 35 at the other end.

Then, the capsule 31 seated in the capsule accommodating part 32 is cut by the capsule cutting pin 43 formed in the lid part 40, and the powdered medicine hermetically stored in the capsule 43 is discharged. When the powder medicine is inhaled with the suction contact pipe 42 of the lid part 40 in the mouth, the powder medicine is mixed with the vaporized vapor discharged into the mixing space 41 through the guide passage 33 As a result, it is possible to reach the lungs of patients with respiratory diseases without loss through the inhalation contact pipe 42.

That is, when a respiratory disease patient inhales the powder medicine discharged from the capsule 31 through the inhalation contact pipe 42, the powder medicine is discharged from the mixing space 41 through the guide passage 33 It can be mixed with the vaporized vapor, and the vaporized vapor in which the powdered drug is mixed can deliver all of the powdered drug to the lungs of patients with respiratory diseases.

delete

In the above, the technical idea of the drug vaporization inhaler of the present invention has been described together with the accompanying drawings, but this is an exemplary description of the most preferred embodiment of the present invention, but does not limit the present invention.

Therefore, the present invention is not limited to the specific embodiments described above, and various modifications can be implemented by anyone having ordinary knowledge in the art to which the present invention belongs without departing from the gist of the present invention claimed in the claims. Of course, such changes are within the scope of the claims.

10; respiratory body 11; battery
12; control board 13; charging terminal block
13a; charging terminal 14; power supply block
14a; heating terminal 20; Particulate Vaporization
21; adsorbed core material bundle 22; heating coil
23; Non-flammable filter 24; top cover
24a; outlet 25; bottom cover
30; body portion 31; capsule
32; capsule accommodating portion 32a; 1st wall member
32b; a second wall member 32c; pin movement path
33; guide oil 33a; horizontal flow
33b; vertical flow path 34; rail home
35; Protrusion insertion groove 40; Cover part
41; mixing space 42; suction contact tube
43; capsule cutting pin 44; lock protrusion
T1, T2; display part

Claims (13)

An inhaler body in which a battery and a control board are accommodated;
a particulate vaporizer accommodated inside the upper end of the inhaler body and generating heat when power is supplied from the battery to vaporize the vaporization accelerating composition;
It is detachably coupled to the upper part of the inhaler body, and on the upper surface is formed a capsule accommodating portion for accommodating a capsule in which a powder drug for patients with respiratory diseases is hermetically stored, and is introduced from the bottom surface as a penetrating type in the upper and lower regions inside the particulate vaporization unit. a body portion having a guide passage for vapor discharge communicating with the particulate vaporization portion so as to eject vaporized vapor derived from the capsule toward the capsule located in the capsule accommodating portion; and,
A mixing space is formed while being rotatably coupled to the upper surface of the body, and has a suction contact pipe for respiratory disease patients communicating with the mixing space and a capsule cutting pin for cutting the capsule accommodated in the capsule receiving portion, wherein the suction a lid portion for inhaling the vaporized vapor through the contact tube or the vaporized vapor discharged from the capsule into the vaporized vapor guided through the guide passage and inhaled into the lungs of patients with respiratory diseases; including,
A charging terminal block having a charging terminal for charging the battery while being electrically connected to the battery is formed at one end of the inhaler body,
At the other end of the inhaler body, a power supply block having a charging terminal for supplying power to the particulate vaporizer while being electrically connected to the control board electrically connected to the battery is formed,
The particulate vaporization unit,
By constituting one disposable cartridge,
An adsorption core material bundle that is provided in a certain length and is filled with the vaporization accelerating composition in an amount of 3 to 5 times;
a heating coil wrapped around a middle portion of the adsorption core bundle and having both ends electrically connected to the charging terminal;
a non-smoke film filter having a cylindrical structure accommodating the adsorption core material bundle around which the heating coil is wound;
an upper cover made of plastic coupled to an upper end of the non-flammable film filter having a cylindrical structure and having a discharge port for discharging vaporization vapor for the vaporization accelerating composition toward the guide passage; and,
a lower cover made of plastic coupled to the lower end of the non-smoke filter forming a cylindrical structure and through which both ends of the heating coil pass through so as to be electrically connected to the charging terminal; A drug vaporization inhaler comprising a. delete delete delete According to claim 1,
The vaporization-accelerating composition is a drug vaporization inhaler, characterized in that any one of minerals, vitamins, amino acids, physiologically active agents. According to claim 1,
The capsule accommodating part,
A pair of plate-shaped first wall members supporting the left and right side surfaces of the capsule, and a pair of plate-shaped wall members facing each other that are installed apart from each other in a direction different from the first wall member to support both ends of the capsule. Equipped with an arc-shaped second wall member,
A drug vaporization inhaler, characterized in that a pin movement path is formed between the plate-shaped first wall member and the arc-shaped second wall member so that one surface of the upper side of the capsule is cut when the lid is rotated. According to claim 1,
The body portion is coupled to the upper part of the inhaler body,
A rail groove for guiding the rotation of the lid is formed on the edge side of the upper surface of the body,
Drug vaporization inhaler, characterized in that the projection insertion groove is formed at both ends of the rail groove. According to claim 7,
A pair of capsule cutting pins protrude from the inner end of the lid,
A drug vaporization inhaler, characterized in that a locking protrusion seated in the protrusion insertion groove of the body portion and rotated along the rail groove is formed on the inner edge side of the cover portion. According to claim 8,
The outer circumferential surface of the body where the protrusion insertion groove is formed and the outer circumferential surface of the lid where the locking protrusion is formed are respectively a discharge position of only vaporized vapor through the suction contact pipe or a vaporized powder medicine discharged from the capsule. A drug vaporization inhaler characterized by forming first and second display portions for guiding a mixed vapor discharging position included in the vapor to be discharged. According to claim 6,
As the guide path,
When the vaporized steam is ejected toward the capsule placed between the body and the lid, it is twisted vertically to form a vortex in the mixing space provided between the lid and the body. A drug vaporization inhaler, characterized in that formed. According to claim 10,
As the guide path,
An “A”-shaped passage connected from the bottom surface of the body to the inner wall surface of the capsule accommodating part is formed, and the inner outlet of the passage is formed by the plate-shaped first wall member and the arc-shaped second wall member in the capsule accommodating part. A drug vaporization inhaler characterized in that it is configured to be located adjacent to the pin movement flow path provided in the space spaced apart therebetween. According to claim 10,
As the guide path,
With a vertical flow path formed to face vertically from the bottom surface of the body portion, and a horizontal flow path connected in a transverse direction from the vertical flow path and having an outlet open to the inner wall surface of the capsule accommodating portion, as a whole, "a" A drug vaporization inhaler characterized in that it is formed to form a connecting passage having a cross section. According to claim 12,
The horizontal passage opened to the inner wall surface of the capsule accommodating part is installed to maintain an inclination of 15 to 45° from the center of the body to one side, and the vapor ejected through the guide passage for vapor discharge via the fine-phase vaporization part. A drug vaporization inhaler, characterized in that the steam is directed to the incision surface of the capsule whose upper side is incised due to the capsular incision pin, and at the same time guides so that a vortex is formed in the mixing space.

Images